DOI: 10.1001/jamadermatol.2026.2912 ISSN: 2168-6068

Variation in Coverage of Atopic Dermatitis Therapies Across Commercial Payers

Claire H. Brennan, Sophie E. Knox, Molly T. Beinfeld, Daniel E. Enright, James D. Chambers

This economic evaluation examines the diagnostic threshold, step therapy, and prescriber requirements from commercial health plans for covering 7 US Food and Drug Administration–approved atopic dermatitis medications.

More from our Archive